IL215733A - 1-Pyrazolo [3,4– c] derivatives, their preparation and medical use - Google Patents

1-Pyrazolo [3,4– c] derivatives, their preparation and medical use

Info

Publication number
IL215733A
IL215733A IL215733A IL21573311A IL215733A IL 215733 A IL215733 A IL 215733A IL 215733 A IL215733 A IL 215733A IL 21573311 A IL21573311 A IL 21573311A IL 215733 A IL215733 A IL 215733A
Authority
IL
Israel
Prior art keywords
pyrazolo
preparation
therapeutic use
isoquinoline derivatives
isoquinoline
Prior art date
Application number
IL215733A
Other languages
English (en)
Hebrew (he)
Other versions
IL215733A0 (en
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL215733A0 publication Critical patent/IL215733A0/en
Publication of IL215733A publication Critical patent/IL215733A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL215733A 2009-04-24 2011-10-11 1-Pyrazolo [3,4– c] derivatives, their preparation and medical use IL215733A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901995A FR2944792B1 (fr) 2009-04-24 2009-04-24 Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique
PCT/FR2010/050773 WO2010122272A1 (fr) 2009-04-24 2010-04-22 DERIVES DE 1-PYRAZOLO[4,3-c]ISOQUINOLEINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
IL215733A0 IL215733A0 (en) 2012-01-31
IL215733A true IL215733A (en) 2014-02-27

Family

ID=41259738

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215733A IL215733A (en) 2009-04-24 2011-10-11 1-Pyrazolo [3,4– c] derivatives, their preparation and medical use

Country Status (25)

Country Link
US (1) US8461175B2 (enExample)
EP (1) EP2421864B1 (enExample)
JP (1) JP5722880B2 (enExample)
KR (1) KR101675609B1 (enExample)
CN (1) CN102459260B (enExample)
AR (1) AR076393A1 (enExample)
AU (1) AU2010240742B2 (enExample)
BR (1) BRPI1013724A2 (enExample)
CA (1) CA2791947A1 (enExample)
CY (1) CY1115678T1 (enExample)
DK (1) DK2421864T3 (enExample)
ES (1) ES2515240T3 (enExample)
FR (1) FR2944792B1 (enExample)
HR (1) HRP20141058T1 (enExample)
IL (1) IL215733A (enExample)
MX (1) MX2011011246A (enExample)
MY (1) MY156362A (enExample)
PL (1) PL2421864T3 (enExample)
PT (1) PT2421864E (enExample)
RU (1) RU2530775C2 (enExample)
SG (1) SG175338A1 (enExample)
SI (1) SI2421864T1 (enExample)
TW (1) TWI468405B (enExample)
UY (1) UY32575A (enExample)
WO (1) WO2010122272A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109020972B (zh) * 2018-10-08 2021-03-09 广东石油化工学院 一种三唑并[1，5-a]喹啉衍生物的制备方法
WO2023039510A1 (en) * 2021-09-10 2023-03-16 The Trustees Of Columbia University In The City Of New York Gpx4 inhibitors and uses thereof
CN116535356A (zh) * 2023-03-06 2023-08-04 中国药科大学 3-氨基-5-苯基-吡唑类衍生物微管蛋白抑制剂及其制备和医药用途
EP4506003A1 (en) 2023-08-07 2025-02-12 S.Yu Yunusov Institute of Chemistry of Plant Substances of the Academy of Sciences of the Republic of Uzbekistan Halogen derivatives of (4´,5´- methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline for use in the treatment of leukemia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600752D0 (en) * 1986-01-14 1986-02-19 Roussel Lab Ltd Chemical compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
US7132428B2 (en) * 2003-07-03 2006-11-07 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
CA2531291A1 (en) * 2003-07-03 2005-02-10 Aventis Pharmaceuticals Inc. Pyrazoloisoquinoline derivatives as kinase inhibitors
AU2004259012C1 (en) * 2003-07-23 2012-08-02 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
AR058223A1 (es) * 2005-11-25 2008-01-23 Palau Pharma Sa Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto

Also Published As

Publication number Publication date
UY32575A (es) 2010-11-30
JP5722880B2 (ja) 2015-05-27
TWI468405B (zh) 2015-01-11
BRPI1013724A2 (pt) 2016-04-05
IL215733A0 (en) 2012-01-31
MX2011011246A (es) 2012-02-13
HK1170736A1 (en) 2013-03-08
WO2010122272A1 (fr) 2010-10-28
TW201041887A (en) 2010-12-01
DK2421864T3 (da) 2014-11-10
FR2944792A1 (fr) 2010-10-29
PT2421864E (pt) 2014-10-07
CN102459260A (zh) 2012-05-16
PL2421864T3 (pl) 2014-12-31
SG175338A1 (en) 2011-11-28
FR2944792B1 (fr) 2011-05-20
EP2421864B1 (fr) 2014-08-06
ES2515240T3 (es) 2014-10-29
RU2011147658A (ru) 2013-05-27
HK1167387A1 (en) 2012-11-30
EP2421864A1 (fr) 2012-02-29
JP2012524766A (ja) 2012-10-18
KR101675609B1 (ko) 2016-11-11
AR076393A1 (es) 2011-06-08
US8461175B2 (en) 2013-06-11
AU2010240742A1 (en) 2011-11-17
SI2421864T1 (sl) 2014-11-28
HRP20141058T1 (hr) 2014-12-19
MY156362A (en) 2016-02-15
RU2530775C2 (ru) 2014-10-10
KR20120007060A (ko) 2012-01-19
CY1115678T1 (el) 2017-01-25
CN102459260B (zh) 2015-06-10
CA2791947A1 (fr) 2010-10-28
AU2010240742B2 (en) 2015-11-19
US20120115898A1 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
IL216226A0 (en) Cyclopenta [c] pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
ZA201005201B (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
IL207078A0 (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
IL201471A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
PL3001903T3 (pl) 1H-pirazolo[3,4-b]pirydyny i ich zastosowania terapeutyczne
ZA201006728B (en) Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives,and preparation and therapeutic use thereof
IL208247A0 (en) Polysubstituted derivatives of 6-heteroaryl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
IL208245A0 (en) Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
IL201450A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
ZA201100210B (en) Pyridino-pyridinone derivatives,preparation thereof,and therapeutic use thereof
IL215286A0 (en) 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
SI2448940T1 (sl) Derivati 6,7,8,9-tetrahidro-pirimido(1,2-a)pirimidin-4-ona, njihova priprava in njihova farmacevtska uporaba
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
IL211141A0 (en) 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof, and therapeutic application thereof
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ZA201209071B (en) 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
IL215733A0 (en) 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
IL206669A0 (en) 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
IL206667A0 (en) 2-HETEROAROYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
EP2578586A4 (en) HEXAHYDROPYRROLO [3,4-B] PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF
ZA201100251B (en) Substituted 1-benzyl-cinnolin-4(1h)-one derivatives,preparation thereof,and therapeutic use thereof
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
IL206672A0 (en) N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees